Drugs / Tdap
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04424693 Comparator | Dec 2020 → Oct 2023 | preeclampsia | Institute of Arthritis Research | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tdap | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04424693 ↗ |
| Modality | Vaccine | “Tdap vaccinations” NCT04424693 ↗ |